Countries Australia
Certa Therapeutics (Certa), a biotechnology company developing innovative precision therapies for patients with fibrotic diseases, today announces the acqu...
December 19, 2024 | News
Clarity has developed a proprietary fibroblast activation protein (FAP)-targeted radiopharmaceutical product that can be used with the perfect pairing of...
December 19, 2024 | News
- Cartherics has received a US$300K G-Rex grant to support its ‘in house’ manufacturing program- Funding will enable Cartherics to generate cru...
December 18, 2024 | News
SK bioscience’s first mRNA vaccine candidate is expected to enter clinical trials in Australia in February 2025, with interim results expected by 2...
December 13, 2024 | News
The Southern Hemisphere’s only mRNA manufacturing facility has officially opened in Victoria, marking a significant milestone for Australia’s h...
December 11, 2024 | News
Late-stage trial in Alzheimer's opens 10 sites in US, with results due in 2025 and 2026 Appoints US-based Chief Commercial Officer, Andrew Udell X...
December 10, 2024 | News
Australian Human Research Ethics Committees approves SKY-0515 treatment for up to 12 weeks in the company's ongoing Phase 1 trial in patients with Hun...
December 10, 2024 | News
First Implants of Innovative Device Completed in the United States and Australia ShiraTronics, a clinical-stage innovator in neuromodulatio...
December 04, 2024 | News
Provides absolute quantitation, essential for precise monitoring of low-abundance targets in clinical diagnostics Enhances lab effic...
November 26, 2024 | News
-Vaxxas, a clinical-stage biotechnology company, has expanded its global intellectual property portfolio to 42 patents, supporting its exclusive claim to m...
November 25, 2024 | News
Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Edith Cowan University Australia (ECU) announced a new strategic p...
November 20, 2024 | News
Telix Pharmaceuticals Limited announces it will expand its theranostic pipeline with new assets targeting Fibroblast Activation Protein (FAP), one of the m...
November 19, 2024 | News
Lixa, a Perth-based biotechnology company, has announced the launch of its first clinical trial to evaluate the safety and tolerability of NeoX-101, an inn...
November 14, 2024 | News
Aravax, a clinical-stage biotechnology company developing next-generation immunotherapies designed to be safe, convenient, and precisely targeted, today an...
November 14, 2024 | News
Most Read
Bio Jobs
News